Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 2,359 | 684 | 0 | 0 | 0 |
| Gross Profit | 2,359 | 684 | N/A | N/A | N/A |
| Operating Expenses | 15,927 | 14,614 | 11,868 | 11,679 | 10,454 |
| Operating Income | -13,567 | -13,930 | -11,868 | -11,679 | -10,454 |
| Other Income | -101 | -1 | -296 | 105 | 302 |
| Pre-tax Income | -13,668 | -13,931 | -12,164 | -11,574 | -10,152 |
| Income Tax | -70 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -13,599 | -13,931 | -11,546 | -11,574 | -10,152 |
| Net Income | $-13,599 | $-13,931 | $-11,546 | $-11,574 | $-10,152 |
| EPS Basic Total Ops | -9.36 | -9.72 | -8.04 | -8.04 | -7.08 |
| EPS Basic Continuous Ops | -9.41 | -9.68 | -8.05 | -8.07 | -7.08 |
| EPS Diluted Total Ops | -9.36 | -9.72 | -8.04 | -8.04 | -7.08 |
| EPS Diluted Continuous Ops | -9.41 | -9.68 | -8.05 | -8.07 | -7.08 |
| EBITDA(a) | $-13,516 | $-13,898 | $-11,843 | $-11,661 | $-10,436 |